
From bispecifics and ADCs to protein degraders and AI-designed mini-proteins, next-generation biologics are pushing discovery teams far beyond the classic antibody paradigm.
In the new BioSpace feature, we explore how integrated protein engineering, structural biology, and AIDD platforms help tame molecular complexity, boost throughput, and design for manufacturability from day one.
If you're navigating complex biologics or planning your next wave of modalities, you'll find plenty of practical insight here.
Read the full article here.
Copyright © Viva Biotech All Rights Reserved. 沪ICP备19036061号